Myeloma cell dynamics in response to treatment supports a model of hierarchical differentiation and clonal evolution

First Page		Document Content
Date: 2016-03-28 11:06:35 RTT Antineoplastic drugs Cancer treatments Oncology Multiple myeloma Bortezomib Melphalan Dexamethasone Chemotherapy Siltuximab Millennium Pharmaceuticals Proteasome inhibitor		Myeloma cell dynamics in response to treatment supports a model of hierarchical differentiation and clonal evolution Add to Reading List Source URL: michorlab.dfci.harvard.edu Download Document from Source Website File Size: 1,05 MB Share Document on Facebook

	PRODUCT MONOGRAPH Pr ELAPRASE* idursulfase DocID: 1qe2f - View Document
	Myeloma cell dynamics in response to treatment supports a model of hierarchical differentiation and clonal evolution DocID: 1ndD8 - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SYLVANT ™ safely and effectively. See full prescribing information for SYLVANT. SYLVANT (siltuximab) for Injection DocID: EYpk - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SYLVANT™ safely and effectively. See full prescribing information for SYLVANT. SYLVANT (siltuximab) for Injection, DocID: oHCJ - View Document